期刊
JOURNAL OF CONTROLLED RELEASE
卷 214, 期 -, 页码 76-84出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2015.07.017
关键词
rHSA nanoparticles; Maghemite; t-PA-ligands to galectins; t-PApeptide 1(LAC); Single photon emission computed tomography-computer tomography (SPECT-CT); Handheld gamma camera; Magnetic resonance imaging (MRI)
资金
- European Union [263307]
- Department of Education, Language Policy and Culture of the Basque Government
Highly aggressive cancer types such as pancreatic cancer possess a mortality rate of up to 80% within the first 6 months after diagnosis. To reduce this high mortality rate, more sensitive diagnostic tools allowing an early stage medical imaging of even very small tumours are needed. For this purpose, magnetic, biodegradable nanoparticles prepared using recombinant human serum albumin (rHSA) and incorporated iron oxide (maghemite, gamma-Fe2O3) nanoparticles were developed. Galectin-1 has been chosen as target receptor as this protein is upregulated in pancreatic cancer and its precursor lesions but not in healthy pancreatic tissue nor in pancreatitis. Tissue plasminogen activator derived peptides (t-PA-ligands), that have a high affinity to galectin-1 have been chosen as target moieties and were covalently attached onto the nanoparticle surface. Improved targeting and imaging properties were shown in mice using single photon emission computed tomography-computer tomography (SPECT-CT), a handheld gamma camera, and magnetic resonance imaging (MRI). (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据